Skip to content

Clinical trials

Observational Schizophrenia trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Observational Country / region: Spain Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20083
20093
20111
20131
20141
20151
20163
20172
20184
20191
20202
20222
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Unknown status6
Active, not recruiting1
Enrolling by invitation1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fundación Marques de Valdecilla6
AstraZeneca5
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau2
Hoffmann-La Roche2
Janssen-Cilag International NV2
Otsuka Pharmaceutical Europe Ltd2
Angelini Farmacéutica1
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla1
GlaxoSmithKline1
Icahn School of Medicine at Mount Sinai1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia29
Psychotic Disorders10
Bipolar Disorder3
Mental Disorders2
Alzheimer Disease1
Anhedonia1
Asthma1
Liver Diseases1
Lung Diseases1
Major Depressive Disorder1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.